Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 204.61
+4.01 (2.00%)
Jul 10, 2026, 3:14 PM IST
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 4.84 billion as of July 10, 2026. Its market cap has increased by 165.73% in one year.
Market Cap
4.84B
Enterprise Value
5.19B
Revenue
1.51B
Ranking
n/a
PE Ratio
43.63
Stock Price
204.61
Market Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 4.84B, an increase of 44,380.43%. That is a compound annual growth rate of 160.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 4.84B | 35.76% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 21.37B |
| Sakar Healthcare | 17.81B |
| Windlas Biotech | 17.13B |
| Jagsonpal Pharmaceuticals | 15.63B |
| Sigachi Industries | 8.49B |
| Valiant Laboratories | 3.38B |
| Nectar Lifesciences | 2.18B |
| Brooks Laboratories | 2.08B |